David Suhrbier
Sleep Medicine · Madera, CANPI 1629070651
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $10,000 of the $12,262 with a category attached, or 81.6%. Livanova USA, Inc. accounts for 91.3% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $8,078 and has fallen 99.3% since, to $58 in 2025.
Across 68 payments — averaging $180.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$11K
- Neurelis, Inc.$150
- AbbVie$126
- UCB, Inc.$120
- Harmony Biosciences LLC$112
- Sunovion Pharmaceuticals Inc.$90
- plus $465 from 13 others
What the payments were for
- Speaking & faculty fees$10,00082%
- Travel & lodging$9888%
- Food & beverage$1,23210%
- Education$420%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$10,738
- VNS - Sentiva$250
- Wakix$112
- VALTOCO$101
How this compares
$12,262 in reported general payments places this provider in the 85th percentile of 200 sleep medicine providers in California.
Other sleep medicine in Madera
- Khalid RaufMadera$7K
- Tabish NazMadera$5K
- Lisa ShivesSan Diego$1.4M
- Haramandeep SinghSan Ramon$1.1M
- Atul MalhotraSan Diego$771K
- Logan SchneiderStanford$506K
- Tony MasriLos Gatos$327K
- Sam KashaniSanta Monica$221K
- Emmanuel MignotStanford$135K
- Jerome HesterPalo Alto$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.